/Companies

Anivive Lifesciences

Long Beach, US · Delaware corporation · 1 known investors

Find your way into Anivive Lifesciences

Sign up to see every warm intro you have to Anivive Lifesciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Anivive Lifesciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Anivive develops new medicines for companion animals, using software across the drug development process to accelerate the creation of treatments. It serves the animal health community, focusing on veterinary and pet health pharmaceuticals.

Founders & leadership

DBDylan Balsz
Dylan BalszFounder, CEO and Chairman
DBDavid Bruyette
David BruyetteChief Medical OfficerDavid Bruyette holds a DVM from the University of Missouri and completed residency training in internal medicine at UC Davis. He has held positions as Head of Internal Medicine at Kansas State University, Medical Director of VCA West Los Angeles Animal Hospital, and staff internist roles, with board certification in veterinary internal medicine and expertise in endocrinology.
RBRobert Bishop
Robert BishopNamed on SEC filing
LDLynne Doti
Lynne DotiNamed on SEC filing
CC
Cheryl CollettNamed on SEC filing
GSGlenn Stearns
Glenn StearnsNamed on SEC filing
SWScott Whitcup
Scott WhitcupNamed on SEC filing
RH
Rick HaugenNamed on SEC filing

Investors · 1

Leonid Capital PartnersreportedWashington

How we know: funding news · press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$44.3M disclosed across 1 of 2 rounds · 2021–2025

▶$44.3MraisedAug 2021 · 78 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert BishopDirector
  • David BruyetteDirector, Executive Officer
  • Lynne DotiDirector
  • Cheryl CollettExecutive Officer
  • Glenn StearnsDirector
  • Scott WhitcupDirector
  • Dylan BalszExecutive Officer, Director
  • Rick HaugenDirector
Offering amount
$44.3M
Amount sold
$44.3M
First sale
Jul 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Companies working in the same space as Anivive Lifesciences.

In the news

Frequently asked questions

What does Anivive Lifesciences do?
Anivive develops new medicines for companion animals, using software across the drug development process to accelerate the creation of treatments. It serves the animal health community, focusing on veterinary and pet health pharmaceuticals.
Who founded Anivive Lifesciences?
Anivive Lifesciences was founded by Dylan Balsz.
Who are Anivive Lifesciences's investors?
Anivive Lifesciences's investors include Leonid Capital Partners.
How much funding has Anivive Lifesciences raised?
Anivive Lifesciences has disclosed $44.3M raised across 1 of its 2 known rounds.
Where is Anivive Lifesciences headquartered?
Anivive Lifesciences is headquartered in Long Beach, US.